Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial.

Autor: Tse P; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada., Yan J; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada., Liu Y; Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada., Jamula E; Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada., Heddle N; Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Canadian Blood Services, Ottawa, Ontario, Canada., Bazin R; Medical Affairs and Innovation, Héma-Québec, Québec City, Québec, Canada., Robitaille N; Héma-Québec, Montreal, Québec, Canada.; Division of Hematology-Oncology, Department of Pediatrics, CHU Sainte-Justine, Montreal, Québec, Canada., Cook R; Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada., Turgeon A; Population Health and Optimal Health Practices Research Unit (Trauma-Emergency-Critical Care Medicine), CHU de Québec - Université Laval Research Center, Québec City, Québec, Canada.; Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec City, Québec, Canada., Fergusson D; Canadian Blood Services, Ottawa, Ontario, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Glesby M; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Loftsgard KC; UBC Health Team-Based Care, Vancouver, British Columbia, USA.; CIHR-Strategy for Patient-Oriented Research, Ottawa, Ontario, Canada., Cushing M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA., Chassé M; Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.; Innovation Hub, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada., Daneman N; Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Finzi A; Centre de Recherche du CHUM, Montreal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Québec, Canada., Sachais B; New York Blood Center, New York, New York, USA.; Weil Cornell Medical College, New York, New York, USA., Bégin P; Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.; Department of Pediatrics, CHU Sainte-Justine, Montreal, Québec, Canada., Callum J; Canadian Blood Services, Ottawa, Ontario, Canada.; Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre and Queen's University, Kingston, Ontario, Canada.; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Arnold DM; Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Xie F; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Publikováno v: Transfusion [Transfusion] 2024 Apr; Vol. 64 (4), pp. 606-614. Date of Electronic Publication: 2024 Mar 21.

Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.

Autor: Britto J; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada., Holbrook A; Department of Medicine, Division of Clinical Pharmacology and Toxicology, McMaster University, Hamilton, Ontario, Canada., Sun H; Division of Hematology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Cserti-Gazdewich C; Department of Medicine/Division of Hematology, University of Toronto and University Health Network, Toronto, Ontario, Canada., Prokopchuk-Gauk O; Department of Pathology and Lab Medicine, University of Saskatchewan, Saskatchewan Health Authority, Canada., Hsia C; Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Khamisa K; Division of Hematology, Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada., Yenson PR; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Sholzberg M; Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Olney HJ; Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Shivakumar S; Division of Hematology, Nova Scotia Health Authority, Halifax, NS, Canada., Jones D; Department of Hematology, Eastern Health, Memorial University, Newfoundland & Labrador, Canada., Merkeley H; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Costello J; Department of Hematology, Eastern Health, Memorial University, Newfoundland & Labrador, Canada., Jamula E; Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada., Arnold DM; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.; Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada.

Publikováno v: Clinical and investigative medicine. Medecine clinique et experimentale [Clin Invest Med] 2024 Mar 01; Vol. 47 (1), pp. 13-22.

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCE.

Autor: Buckstein R; Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Callum J; Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre and Queen's University, Kingston, Ontario, Canada., Prica A; Department of Medicine, Princess Margaret Hospital, United Health Network, Toronto, Ontario, Canada., Bowen D; Department of Medicine, University of York, York, UK., Wells RA; Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Leber B; Department of Medicine, Mcmaster University, Hamilton, Ontario, Canada., Heddle N; Mcmaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Chodirker L; Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Cheung M; Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Mozessohn L; Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Yee K; Department of Medicine, Princess Margaret Hospital, United Health Network, Toronto, Ontario, Canada., Gallagher J; Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Parmentier A; Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Jamula E; Department of Medicine, Mcmaster University, Hamilton, Ontario, Canada., Zhang L; MacroStat Inc, Toronto, Ontario, Canada., Mamedov A; Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Stanworth SJ; NHS Blood and Transplant, Oxford, UK.; Oxford University NHS Trust, The John Radcliffe Hospital, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Lin Y; Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Publikováno v: Transfusion [Transfusion] 2024 Feb; Vol. 64 (2), pp. 223-235. Date of Electronic Publication: 2024 Feb 07.

A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma.

Autor: Li N; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Computing and Software, McMaster University, Hamilton, Ontario, Canada., Zeller MP; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.; Canadian Blood Services, Ottawa, Ontario, Canada., Shih AW; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, Vancouver Coastal Health Authority, Vancouver, British Columbia, Canada.; Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada., Heddle NM; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Canadian Blood Services, Ottawa, Ontario, Canada., St John M; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Bégin P; Section of Allergy, Immunology and Rheumatology, Department of Pediatrics, CHU Sainte-Justine, Montréal, Québec, Canada.; Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada., Callum J; Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre and Queen's University, Kingston, Ontario, Canada.; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Arnold DM; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.; Canadian Blood Services, Ottawa, Ontario, Canada., Akbari-Moghaddam M; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Down DG; Department of Computing and Software, McMaster University, Hamilton, Ontario, Canada., Jamula E; McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Devine DV; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Canadian Blood Services, Vancouver, British Columbia, Canada., Tinmouth A; Canadian Blood Services, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Publikováno v: Transfusion [Transfusion] 2022 Dec; Vol. 62 (12), pp. 2525-2538. Date of Electronic Publication: 2022 Oct 26.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.